Fiscal Period | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Period End Date | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
Cash | 33.89 | 40.27 | 19.20 | 14.30 |
Cash Equivalents | 1,340.79 | 440.70 | 607.59 | 266.49 |
Short Term Investments | 30.54 | 30.10 | 0.00 | 7.27 |
Cashand Short Term Investments | 1,405.22 | 511.07 | 626.79 | 288.06 |
Accounts Receivable- Trade Net | 336.12 | 385.36 | 387.80 | 411.16 |
Total Receivables Net | 357.63 | 394.51 | 406.64 | 428.28 |
Total Inventory | 76.23 | 61.36 | 53.80 | 43.37 |
Prepaid Expenses | 10.60 | 15.01 | 11.10 | 8.61 |
Other Current Assets Total | 93.39 | 18.34 | 26.14 | - |
Total Current Assets | 1,943.07 | 1,000.29 | 1,124.47 | 768.32 |
Property/ Plant/ Equipment Total- Gross | 2,961.36 | 2,665.35 | 2,254.56 | 1,533.85 |
Accumulated Depreciation Total | -735.73 | -607.04 | -479.65 | -385.56 |
Property/ Plant/ Equipment Total- Net | 2,225.63 | 2,058.31 | 1,774.91 | 1,148.29 |
Goodwill Net | 2,454.66 | 2,454.66 | 2,454.66 | 285.39 |
Intangibles Net | 2,610.84 | 2,655.73 | 2,333.74 | 951.70 |
Long Term Investments | 206.54 | 276.29 | 0.51 | 0.51 |
Note Receivable- Long Term | 460.69 | 556.92 | 680.02 | 580.66 |
Other Long Term Assets Total | 200.42 | 186.93 | 176.13 | 89.51 |
Total Assets | 10,101.85 | 9,189.13 | 8,544.44 | 3,824.38 |
Accounts Payable | 543.46 | 452.08 | 435.69 | 293.52 |
Notes Payable/ Short Term Debt | 68.24 | 0.00 | 54.25 | 0.00 |
Current Portof LT Debt/ Capital Leases | 16.26 | 113.80 | 34.35 | 510.86 |
Other Currentliabilities Total | 417.61 | 191.39 | 252.64 | 658.09 |
Total Current Liabilities | 1,045.57 | 757.27 | 776.93 | 1,474.42 |
Long Term Debt | 492.88 | 624.60 | 838.85 | 788.32 |
Capital Lease Obligations | 111.58 | 174.98 | 173.96 | 1.56 |
Total Long Term Debt | 604.46 | 799.58 | 1,012.81 | 789.88 |
Total Debt | 688.96 | 913.38 | 1,101.41 | 1,300.74 |
Deferred Income Tax | 437.13 | 681.41 | 581.92 | 341.63 |
Other Liabilities Total | 605.10 | 668.40 | 534.10 | 231.04 |
Total Liabilities | 2,692.26 | 2,906.66 | 2,905.76 | 2,836.97 |
Common Stock Total | 970.92 | 969.61 | 965.95 | 537.24 |
Additional Paid- In Capital | 5,158.03 | 5,143.13 | 5,104.81 | 1,076.78 |
Retained Earnings( Accumulated Deficit) | 1,280.64 | 169.73 | -432.08 | -626.61 |
Total Equity | 7,409.59 | 6,282.47 | 5,638.68 | 987.41 |
Total Liabilities Shareholders' Equity | 10,101.85 | 9,189.13 | 8,544.44 | 3,824.38 |
Total Common Shares Outstanding | 97.09 | 96.96 | 96.59 | 91.07 |
Tangible Book Valueper Share Common Eq | 24.14 | 12.09 | 8.80 | -2.74 |
Accrued Expenses | - | - | - | 11.95 |
Max Healthcare Institute Dividend | Max Healthcare Institute Bonus | Max Healthcare Institute News | Max Healthcare Institute AGM | Max Healthcare Institute Rights | Max Healthcare Institute Splits | Max Healthcare Institute Board Meetings | Max Healthcare Institute Key Metrics | Max Healthcare Institute Shareholdings | Max Healthcare Institute Profit Loss | Max Healthcare Institute Cashflow | Max Healthcare Institute Q1 Results | Max Healthcare Institute Q2 Results | Max Healthcare Institute Q3 Results | Max Healthcare Institute Q4 Results
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks